Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Chuikyo Applies Medical Insurance To Regenerated Skin Product

This article was originally published in PharmAsia News

Executive Summary

Japan's Central Social Medical Insurance Agency (Chuikyo) decided Dec. 17 to include JACE regenerated skin as a reimbursable item for medical insurance beginning in January 2009. Manufactured and marketed by Aichi-based regeneration medical company Japan Tissue Engineering, JACE is priced at ¥306,000 per 80 square meters. The product uses a patient's own skin and treats patients with high class (over 30 percent of body) burns. After reimbursement, patients will be able to get the treatment for a fraction of the price, which otherwise could be as much as ¥10 million per month. Since the product obtained MHLW approval last October, a discussion over safety issues had delayed the reimbursement decision until now. (Click here for more - Japanese language

Latest Headlines
See All
UsernamePublicRestriction

Register

SC067464

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel